Oxford Biomedica's process development services optimize yield and quality, reducing time and costs for clinical trials. Their serum-free, animal component-free processes enhance productivity, ensuring robust, reproducible, and commercially viable solutions for gene and cell therapy.
Vendor
Oxford Biomedica
Company Website
Unparalleled process development services
Maximise yield and improve quality Lean on our process development expertise to help you reduce the time and expense involved in getting your next life-changing therapy to first clinical trial and beyond. We’ll collaborate with you to develop a strategy that streamlines your product development cycles and maximises yield – so you can increase your speed to clinic.
Serum-free production processes
Our serum and animal component free suspension processes use chemically defined media and supplements. This maximises volumetric productivity for a significant reduction in the vector cost per dose. We’re all working towards the same end goal: to make cell and gene therapy universally available and affordable so that more patients can benefit from life saving interventions sooner.